Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 8, 2019

Study Completion Date

October 8, 2019

Conditions
Prostate Cancer
Interventions
DRUG

Abiraterone acetate

DRUG

Prednisone

Trial Locations (14)

23666

Virginia Oncology Associates, Hampton

27157

Wake Forest University, Winston-Salem

27536

Maria Parham Medical Center, Henderson

27577

Johnston Memorial Hospital, Smithfield

27599

University of North Carolina, Chapel Hill

27609

Duke Raleigh Hospital, Raleigh

27710

Duke University Medical Center, Durham

28144

W. G. 'Bill' Hefner VA Medical Center, Salisbury

28352

Scotland Memorial Hospital, Laurinburg

28359

Southeastern Regional, Lumberton

29303

Spartanburg Regional, Spartanburg

35233

Birmingham VA Medical Center, Birmingham

48201

Karmanos Cancer Institute, Detroit

70112

Tulane Cancer Center, New Orleans

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER